analytica Anacon India

analytica Anacon India

“analytica Anacon India and India Lab Expo are together the biggest show in laboratory technology, analysis and biotechnology in India. The international trade fair is the most important industry gathering in India. Get to know the entire range of topics that pertain to laboratories in research and industry.

Key facts about analytica Anacon India and India Lab Expo:
7,714 trade visitors
259 exhibitors from 11 countries
10,500 square meters total space (gross)
852 face to face buyer seller meetings”
“analytica Anacon India and India Lab Expo are together the biggest show in laboratory technology, analysis and biotechnology in India. The international trade fair is the most important industry gathering in India. Get to know the entire range of topics that pertain to laboratories in research and industry.

Key facts about analytica Anacon India and India Lab Expo:
7,714 trade visitors
259 exhibitors from 11 countries
10,500 square meters total space (gross)
852 face to face buyer seller meetings”
“analytica Anacon India and India Lab Expo are together the biggest show in laboratory technology, analysis and biotechnology in India. The international trade fair is the most important industry gathering in India. Get to know the entire range of topics that pertain to laboratories in research and industry.

Key facts about analytica Anacon India and India Lab Expo:
7,714 trade visitors
259 exhibitors from 11 countries
10,500 square meters total space (gross)
852 face to face buyer seller meetings”
“analytica Anacon India and India Lab Expo are together the biggest show in laboratory technology, analysis and biotechnology in India. The international trade fair is the most important industry gathering in India. Get to know the entire range of topics that pertain to laboratories in research and industry.

Key facts about analytica Anacon India and India Lab Expo:
7,714 trade visitors
259 exhibitors from 11 countries
10,500 square meters total space (gross)
852 face to face buyer seller meetings”

India Lab Expo

India Lab Expo

“The 10th annual edition of analytica Anacon India and India Lab Expo successfully concluded in Hyderabad at HITEX Exhibition Center. 259 exhibitors from 11 countries showcased products, recent developments and market trends from laboratory instruments, analysis, diagnostics and biotechnology from September 21 to 23, 2017. The trade fair witnessed a growth in visitors as compared to the previous year, resulting to 7,714 trade visitors.

This year the event will be spread across 10500 sq mtr of business space covering the entire range of analysis, laboratory technology, biotechnology and diagnostics. The event also offers various supporting programs bringing together the top players from the analytical & laboratory industry.”
“The 10th annual edition of analytica Anacon India and India Lab Expo successfully concluded in Hyderabad at HITEX Exhibition Center. 259 exhibitors from 11 countries showcased products, recent developments and market trends from laboratory instruments, analysis, diagnostics and biotechnology from September 21 to 23, 2017. The trade fair witnessed a growth in visitors as compared to the previous year, resulting to 7,714 trade visitors.

This year the event will be spread across 10500 sq mtr of business space covering the entire range of analysis, laboratory technology, biotechnology and diagnostics. The event also offers various supporting programs bringing together the top players from the analytical & laboratory industry.”
“The 10th annual edition of analytica Anacon India and India Lab Expo successfully concluded in Hyderabad at HITEX Exhibition Center. 259 exhibitors from 11 countries showcased products, recent developments and market trends from laboratory instruments, analysis, diagnostics and biotechnology from September 21 to 23, 2017. The trade fair witnessed a growth in visitors as compared to the previous year, resulting to 7,714 trade visitors.

This year the event will be spread across 10500 sq mtr of business space covering the entire range of analysis, laboratory technology, biotechnology and diagnostics. The event also offers various supporting programs bringing together the top players from the analytical & laboratory industry.”

6th Annual Conference on Parasitology & Infectious Diseases

6th Annual Conference on Parasitology & Infectious Diseases

6th Annual Conference on Parasitology & Infectious Diseases conference throughout November 15-16, 2018 to be held in Istanbul, Turkey which incorporates prompt keynote displays, Oral talks, Poster displays and Exhibitions. The Theme of this conference is A New Era of Science in Parasitology and Infectious Diseases.
Parasitology specialise in innovative technologies which might forestall in unfold of infectious diseases. This gathering incorporates exalting intelligent displays and keynote speakers UN agency can provides a universal stage to discourse of present and future difficulties about Parasitology and Infectious Diseases.
6th Annual Conference on Parasitology & Infectious Diseases conference throughout November 15-16, 2018 to be held in Istanbul, Turkey which incorporates prompt keynote displays, Oral talks, Poster displays and Exhibitions. The Theme of this conference is A New Era of Science in Parasitology and Infectious Diseases.
Parasitology specialise in innovative technologies which might forestall in unfold of infectious diseases. This gathering incorporates exalting intelligent displays and keynote speakers UN agency can provides a universal stage to discourse of present and future difficulties about Parasitology and Infectious Diseases.
6th Annual Conference on Parasitology & Infectious Diseases conference throughout November 15-16, 2018 to be held in Istanbul, Turkey which incorporates prompt keynote displays, Oral talks, Poster displays and Exhibitions. The Theme of this conference is A New Era of Science in Parasitology and Infectious Diseases.
Parasitology specialise in innovative technologies which might forestall in unfold of infectious diseases. This gathering incorporates exalting intelligent displays and keynote speakers UN agency can provides a universal stage to discourse of present and future difficulties about Parasitology and Infectious Diseases.
6th Annual Conference on Parasitology & Infectious Diseases conference throughout November 15-16, 2018 to be held in Istanbul, Turkey which incorporates prompt keynote displays, Oral talks, Poster displays and Exhibitions. The Theme of this conference is A New Era of Science in Parasitology and Infectious Diseases.
Parasitology specialise in innovative technologies which might forestall in unfold of infectious diseases. This gathering incorporates exalting intelligent displays and keynote speakers UN agency can provides a universal stage to discourse of present and future difficulties about Parasitology and Infectious Diseases.

Product Stability Testing Program Seminar

Product Stability Testing Program Seminar

This seminar will provide a great resource to Pharmaceutical, Biotechnology, Diagnostics, Cell Therapy, Drugs, Biologics, OTC, Radio-pharmaceutical, Pharmacies and Medical Device Industries in understanding the effective way to establish a new or modified product stability testing program. This program is an important part of a product’s regulatory filing requirements as well as the determination of the shelf life or expiration date of the product. This is an important part of every business final bottom line or indirectly relationship to their supply and warehouse chain (how long the product can be stored before it can be discarded). Understanding how to design and implement an effective stability testing program following the regulatory guidelines will allow the product to be manufactured, tested, released, adequately stored and effectively tested for stability and ultimately used through its actual end point based on the product’s potency. This will eliminate potential loss of product and business income by manufacturers of product (i.e. when a potent product is inadvertently discarded due to a poorly designed stability testing program) which ends up impacting the products’ regulatory filing status or a product’s Regulatory Filing/Application. The focus of this seminar will create a detailed process that will guide the attendees in the right direction in the planning of a new or existing product’s stability testing plan, program, protocol, handing and utilizing the data, setting the shelf life as well as the applicable regulatory requirements.
This seminar will provide a great resource to Pharmaceutical, Biotechnology, Diagnostics, Cell Therapy, Drugs, Biologics, OTC, Radio-pharmaceutical, Pharmacies and Medical Device Industries in understanding the effective way to establish a new or modified product stability testing program. This program is an important part of a product’s regulatory filing requirements as well as the determination of the shelf life or expiration date of the product. This is an important part of every business final bottom line or indirectly relationship to their supply and warehouse chain (how long the product can be stored before it can be discarded). Understanding how to design and implement an effective stability testing program following the regulatory guidelines will allow the product to be manufactured, tested, released, adequately stored and effectively tested for stability and ultimately used through its actual end point based on the product’s potency. This will eliminate potential loss of product and business income by manufacturers of product (i.e. when a potent product is inadvertently discarded due to a poorly designed stability testing program) which ends up impacting the products’ regulatory filing status or a product’s Regulatory Filing/Application. The focus of this seminar will create a detailed process that will guide the attendees in the right direction in the planning of a new or existing product’s stability testing plan, program, protocol, handing and utilizing the data, setting the shelf life as well as the applicable regulatory requirements.
This seminar will provide a great resource to Pharmaceutical, Biotechnology, Diagnostics, Cell Therapy, Drugs, Biologics, OTC, Radio-pharmaceutical, Pharmacies and Medical Device Industries in understanding the effective way to establish a new or modified product stability testing program. This program is an important part of a product’s regulatory filing requirements as well as the determination of the shelf life or expiration date of the product. This is an important part of every business final bottom line or indirectly relationship to their supply and warehouse chain (how long the product can be stored before it can be discarded). Understanding how to design and implement an effective stability testing program following the regulatory guidelines will allow the product to be manufactured, tested, released, adequately stored and effectively tested for stability and ultimately used through its actual end point based on the product’s potency. This will eliminate potential loss of product and business income by manufacturers of product (i.e. when a potent product is inadvertently discarded due to a poorly designed stability testing program) which ends up impacting the products’ regulatory filing status or a product’s Regulatory Filing/Application. The focus of this seminar will create a detailed process that will guide the attendees in the right direction in the planning of a new or existing product’s stability testing plan, program, protocol, handing and utilizing the data, setting the shelf life as well as the applicable regulatory requirements.

cGMP Raw Material Requirements Seminar

cGMP Raw Material Requirements Seminar

“This highly interactive two day seminar on raw material requirements in a cGMP environment will:

Consider FDA, Health Canada, ICH, USP and EP requirements.
Examine a variety of the issues surrounding raw materials to include what materials should be tested and to what extent during Phase 1, 2, 3 and commercial production.
Cover testing requirements during each Phase (Phase appropriate), to include microbial and endotoxin, and what may be optional (regulatory risk) until the product moves to its next Phase.
Determine what options exist – even within a Phase 2 or Phase 3 testing framework.
Discuss compendial vs. non-compendial testing and how to respond when no method is available.
Discuss how a 90 percent vs. a 90.0 percent minimum purity analysis can delay initiation of testing.
Explore the number of lots required for testing before reduced testing might occur and why some companies don’t accept this route.
Review the use of individual samples vs. composite samples for testing.
Explore ASQ testing to include how to choose attributes and sample size”
“This highly interactive two day seminar on raw material requirements in a cGMP environment will:

Consider FDA, Health Canada, ICH, USP and EP requirements.
Examine a variety of the issues surrounding raw materials to include what materials should be tested and to what extent during Phase 1, 2, 3 and commercial production.
Cover testing requirements during each Phase (Phase appropriate), to include microbial and endotoxin, and what may be optional (regulatory risk) until the product moves to its next Phase.
Determine what options exist – even within a Phase 2 or Phase 3 testing framework.
Discuss compendial vs. non-compendial testing and how to respond when no method is available.
Discuss how a 90 percent vs. a 90.0 percent minimum purity analysis can delay initiation of testing.
Explore the number of lots required for testing before reduced testing might occur and why some companies don’t accept this route.
Review the use of individual samples vs. composite samples for testing.
Explore ASQ testing to include how to choose attributes and sample size”

Quality Control Laboratory Compliance Seminar

Quality Control Laboratory Compliance Seminar

FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries – pharmaceuticals, biologics, medical devices, as well as foods and cosmetics – as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries – pharmaceuticals, biologics, medical devices, as well as foods and cosmetics – as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries – pharmaceuticals, biologics, medical devices, as well as foods and cosmetics – as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries – pharmaceuticals, biologics, medical devices, as well as foods and cosmetics – as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries – pharmaceuticals, biologics, medical devices, as well as foods and cosmetics – as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.

eCTD Submissions Seminar

eCTD Submissions Seminar

“The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD – Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies. Reformatting for multiple submissions is substantially limited. The CTD has improved the regulatory review processes and enabled implementation of good review practices. The eCTD has increased efficiency for reviewers and improved submission times.

This two day workshop will provide you with an in-depth review of the content and format requirements of the CTD/eCTD. Hands-on activities will include organizing specific study reports and other documents into the CTD, using tools for the project management of the CTD preparation, and pre-publishing an eCTD.”
“The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD – Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies. Reformatting for multiple submissions is substantially limited. The CTD has improved the regulatory review processes and enabled implementation of good review practices. The eCTD has increased efficiency for reviewers and improved submission times.

This two day workshop will provide you with an in-depth review of the content and format requirements of the CTD/eCTD. Hands-on activities will include organizing specific study reports and other documents into the CTD, using tools for the project management of the CTD preparation, and pre-publishing an eCTD.”
“The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD – Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies. Reformatting for multiple submissions is substantially limited. The CTD has improved the regulatory review processes and enabled implementation of good review practices. The eCTD has increased efficiency for reviewers and improved submission times.

This two day workshop will provide you with an in-depth review of the content and format requirements of the CTD/eCTD. Hands-on activities will include organizing specific study reports and other documents into the CTD, using tools for the project management of the CTD preparation, and pre-publishing an eCTD.”

Phase I Clinical Trial – GMP Expectations: Seminar

Phase I Clinical Trial – GMP Expectations: Seminar

Because a phase 1 clinical trial initially introduces an investigational new drug into human subjects, appropriate CGMP help ensure subject safety. It is important to implement quality control (QC) principles to the manufacture of phase 1 investigational drugs (i.e., interpreting and implementing CGMP consistent with good scientific methodology), which foster CGMP activities that are more appropriate for phase 1 clinical trials, improve the quality of phase 1 investigational drugs, and facilitate the initiation of investigational clinical trials in humans while continuing to protect trial subjects.
Because a phase 1 clinical trial initially introduces an investigational new drug into human subjects, appropriate CGMP help ensure subject safety. It is important to implement quality control (QC) principles to the manufacture of phase 1 investigational drugs (i.e., interpreting and implementing CGMP consistent with good scientific methodology), which foster CGMP activities that are more appropriate for phase 1 clinical trials, improve the quality of phase 1 investigational drugs, and facilitate the initiation of investigational clinical trials in humans while continuing to protect trial subjects.
Because a phase 1 clinical trial initially introduces an investigational new drug into human subjects, appropriate CGMP help ensure subject safety. It is important to implement quality control (QC) principles to the manufacture of phase 1 investigational drugs (i.e., interpreting and implementing CGMP consistent with good scientific methodology), which foster CGMP activities that are more appropriate for phase 1 clinical trials, improve the quality of phase 1 investigational drugs, and facilitate the initiation of investigational clinical trials in humans while continuing to protect trial subjects.
Because a phase 1 clinical trial initially introduces an investigational new drug into human subjects, appropriate CGMP help ensure subject safety. It is important to implement quality control (QC) principles to the manufacture of phase 1 investigational drugs (i.e., interpreting and implementing CGMP consistent with good scientific methodology), which foster CGMP activities that are more appropriate for phase 1 clinical trials, improve the quality of phase 1 investigational drugs, and facilitate the initiation of investigational clinical trials in humans while continuing to protect trial subjects.

Water System Monitoring and Microbial Control Seminar

Water System Monitoring and Microbial Control Seminar

This course is designed to provide a microbiology-focused education about all aspects of water systems and how biofilm manages to thrive there. Prior microbiological education or training, though a plus, is not a requirement, since this training is for everyone involved with water systems, from the lab to utility room operations. The instructor will provide the necessary background needed to understand this very important subject matter. This understanding is essential for the proper design, validation, operation, monitoring, and maintenance of a high purity water system. Without this understanding, water system control and monitoring consists of a set of rules that often don’t work or result in erroneous monitoring data and can cause everything from very costly and unnecessary system downtime to patient injury and product recalls.
This course is designed to provide a microbiology-focused education about all aspects of water systems and how biofilm manages to thrive there. Prior microbiological education or training, though a plus, is not a requirement, since this training is for everyone involved with water systems, from the lab to utility room operations. The instructor will provide the necessary background needed to understand this very important subject matter. This understanding is essential for the proper design, validation, operation, monitoring, and maintenance of a high purity water system. Without this understanding, water system control and monitoring consists of a set of rules that often don’t work or result in erroneous monitoring data and can cause everything from very costly and unnecessary system downtime to patient injury and product recalls.
This course is designed to provide a microbiology-focused education about all aspects of water systems and how biofilm manages to thrive there. Prior microbiological education or training, though a plus, is not a requirement, since this training is for everyone involved with water systems, from the lab to utility room operations. The instructor will provide the necessary background needed to understand this very important subject matter. This understanding is essential for the proper design, validation, operation, monitoring, and maintenance of a high purity water system. Without this understanding, water system control and monitoring consists of a set of rules that often don’t work or result in erroneous monitoring data and can cause everything from very costly and unnecessary system downtime to patient injury and product recalls.

International Pediatric Critical Care Conference of India – IPCCI 2018

International Pediatric Critical Care Conference of India – IPCCI 2018

It is our great pleasure to invite you to participate in the 1st International Pediatric Critical Care Conference of India (IPCCI-2018) which will be held from October 20th-23rd, 2018 at HICC, Hyderabad.

This innovative conference will include presentations and discussions on promoting, learning and collaboration for the care we provide to children with critical illness and their families.

National and International domain experts from across the globe will lead academic deliberations and represent their point of views.

We humbly invite to participate in this great effort by becoming the sponsors for the conference in various categories.

Industry support is vital to the success of this conference and demonstrates your commitment to improving patient care.
It is our great pleasure to invite you to participate in the 1st International Pediatric Critical Care Conference of India (IPCCI-2018) which will be held from October 20th-23rd, 2018 at HICC, Hyderabad.

This innovative conference will include presentations and discussions on promoting, learning and collaboration for the care we provide to children with critical illness and their families.

National and International domain experts from across the globe will lead academic deliberations and represent their point of views.

We humbly invite to participate in this great effort by becoming the sponsors for the conference in various categories.

Industry support is vital to the success of this conference and demonstrates your commitment to improving patient care.
It is our great pleasure to invite you to participate in the 1st International Pediatric Critical Care Conference of India (IPCCI-2018) which will be held from October 20th-23rd, 2018 at HICC, Hyderabad.

This innovative conference will include presentations and discussions on promoting, learning and collaboration for the care we provide to children with critical illness and their families.

National and International domain experts from across the globe will lead academic deliberations and represent their point of views.

We humbly invite to participate in this great effort by becoming the sponsors for the conference in various categories.

Industry support is vital to the success of this conference and demonstrates your commitment to improving patient care.